Literature DB >> 12669135

Incidence of thromboembolic events in Lebanese thalassemia intermedia patients.

P A Zalloua, H Shbaklo, Y Abou Mourad, S Koussa, A Taher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669135

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  10 in total

Review 1.  Hypercoagulability in congenital haemolytic anaemias.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2012-10-25       Impact factor: 3.443

Review 2.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Massive pulmonary embolism in a Lebanese patient doubly heterozygous for MTHFR and Factor V Leiden presenting with syncope and treated with tenecteplase.

Authors:  Hussain Isma'eel; Ali Taher; Samir Alam; M Samir Arnaout
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

4.  Genetic thrombophilia in patients with VTE in eastern Mediterranean located tertiary care center; is it time to change the algorithm for thrombophilia work up decision making?

Authors:  H Isma'eel; R El Accaoui; W Shamseddeen; A Taher; S Alam; R Mahfouz; M S Arnaout
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

5.  Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.

Authors:  Zohreh Rahimi; Mandana Ghaderi; Ronald L Nagel; Adriana Muniz
Journal:  J Thromb Thrombolysis       Date:  2007-11-04       Impact factor: 2.300

6.  Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma.

Authors:  Armando Tripodi; Maria Domenica Cappellini; Veena Chantarangkul; Lidia Padovan; Maria Rosaria Fasulo; Alessia Marcon; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2009-07-31       Impact factor: 9.941

7.  Coagulopathy in Beta-thalassemia: current understanding and future perspectives.

Authors:  M Domenica Cappellini; Khaled M Musallam; Alessia Marcon; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

8.  Thalassemia and venous thromboembolism.

Authors:  Julien Succar; Khaled M Musallam; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-25       Impact factor: 2.576

9.  Pulmonary Embolism in a Sarcoidosis Patient Double Heterozygous for Methylenetetrahydrofolate Reductase Gene Polymorphisms and Factor V Leiden and Homozygous for the D-Allele of Angiotensin Converting Enzyme Gene.

Authors:  Nadim El-Majzoub; Rami Mahfouz; Nadim Kanj
Journal:  Case Rep Med       Date:  2015-08-11

10.  Impact of Genetic Polymorphism of methylenetetrahydrofolate reductase C677T on Development of Hyperhomocysteinemia and Related Oxidative Changes in Egyptian β-Thalassemia Major Patients.

Authors:  Mai A Abd-Elmawla; Sherine M Rizk; Ilham Youssry; Amira A Shaheen
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.